| Answers |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Finance > Personal Finance > Critical Illness Cover - Insuring The Children |
|
Answers - Critical Illness Cover - Insuring The Children
It's not a subject any of us like to dwell upon, but cancer is a fact of modern life. The good news is that advances in According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product treatment and medication mean that cancer is not the automatic death sentence it once was. Sometimes an even harder su ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ject to comtemplate is children contracting cancer. The number of children who survive cancer has doubled over the last lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. 30 years, according to the Cancer Research Campaign. In fact, 7 in 10 now survive the disease compared to 3 in 10 in the here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe 1960s. Unfortunately, the incidence of childhood cancer has not changed very much over the last 40 years. In 2000 there d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro were around 1,400 new cases diagnosed in Great Britain, with 1/3 of these being leukaemia (source: National Statistics O ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc line). When buying critical illness cover your priority may not be covering your children, however when you think about easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi the impact that a sick child could have on a parent's personal and professional life, it makes sense to ensure it's inc nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically uded in the policy that you purchase. The good news is that children's critical illness cover is an additional benefit and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ f almost every policy on the market, and comes at no extra cost. The claim amount is normally a percentage of the sum a ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi sured up to a certain limit (e.g. ?15,000) and applies between the ages of 30 days and 18 years. Claims are assessed aga ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a nst a cut-down version of the adult conditions. Also, a claim under children's critical illness will not affect the pare dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod t's cover or cause the policy to come to an end. Whilst heart attack and cancer are the two major causes of adult claim cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin , they are only ranked 5th and 6th for children's claims (depending on the provider). What could the money be used towa tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen rds in the event of a claim under the children's cover? Well, it could be used for: - medical treatment - nursing car t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel - allow parents time off work - special trip/holiday In summary, the fact that children's cover is automatically inc ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust uded in critical illness policies is a fantastic add on. In the unfortunate event of a claim, parents and prospective pa y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ents will always appreciate the value of this benefit. The Financial Tips Bottom Line If you have critical illness cov . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de r, take the time to analyse your existing policy to ensure children's cover is included. You should find this in the pol elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip cy details. If you're unable to find it simply call the provider and they should be able to provide you with the details tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:The Worst SEO Mistakes That Lead To Lowering Your Search Engine Ranking
|